Pellucid marginal degeneration

From WikiMD's Medical Encyclopedia

Revision as of 16:24, 22 May 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

File:The eye & I.jpg
The_eye_&_I.jpg

Pellucid marginal degeneration (PMD) is a rare, bilateral, non-inflammatory corneal thinning disorder characterized by a peripheral band of thinning, typically located in the inferior cornea. This condition leads to irregular astigmatism and can significantly affect visual acuity.

Presentation

Patients with PMD often present with progressive visual impairment due to the irregular astigmatism induced by the corneal thinning. Unlike keratoconus, another corneal ectatic disorder, PMD does not typically present with corneal scarring or Vogt's striae. The hallmark of PMD is a clear, crescent-shaped band of thinning located 1-2 mm from the inferior limbus, with the area of maximum thinning being peripheral to the visual axis.

Diagnosis

The diagnosis of PMD is primarily clinical, supported by imaging techniques such as corneal topography and corneal tomography. These imaging modalities reveal a characteristic "kissing doves" or "crab claw" pattern on the topographic map. Pachymetry can be used to measure the corneal thickness and confirm the peripheral thinning.

Differential Diagnosis

PMD must be differentiated from other corneal ectatic disorders, including keratoconus, keratoglobus, and Terrien's marginal degeneration. Unlike keratoconus, PMD does not typically present with central corneal thinning or apical protrusion. Keratoglobus involves generalized corneal thinning, and Terrien's marginal degeneration is associated with vascularization and lipid deposition.

Management

Management of PMD focuses on correcting the irregular astigmatism to improve visual acuity. Options include:

Prognosis

The prognosis for patients with PMD varies. With appropriate management, many patients can achieve satisfactory visual acuity. However, the progressive nature of the disease may necessitate ongoing adjustments in the management plan.

See Also

References

External Links


Stub icon
   This article is a ophthalmology stub. You can help WikiMD by expanding it!




Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!



Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.